ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents)Review Published on 2018-06-012023-06-19 Journal: Clinical microbiology and infection : the official [Category] B형 간염, [키워드] adalimumab certolizumab pegol Etanercept Golimumab Infection infliximab prevention Tuberculosis Tumour necrosis factor-α. [DOI] 10.1016/j.cmi.2017.12.025 [Article Type] Review
Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumabResearch Article Published on 2016-11-242024-09-02 Journal: Arthritis Research & Therapy [Category] 대상포진, [키워드] adalimumab drug surveillance Etanercept JADAS juvenile idiopathic arthritis Tocilizumab [DOI] 10.1186/s13075-016-1170-3 PMC 바로가기 [Article Type] Research Article
Safety of Adalimumab and Predictors of Adverse Events in 1693 Japanese Patients with Crohn’s DiseaseOriginal Article Published on 2016-09-092024-09-02 Journal: Journal of Crohn's & colitis [Category] 대상포진, [키워드] adalimumab Crohn’s disease post-marketing study [DOI] 10.1093/ecco-jcc/jjw060 PMC 바로가기 [Article Type] Original Article
Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritisResearch Article Published on 2016-06-232024-09-02 Journal: Arthritis Research & Therapy [Category] 대상포진, [키워드] adalimumab Drug switching Efficacy rheumatoid arthritis Safety Tofacitinib [DOI] 10.1186/s13075-016-1049-3 PMC 바로가기 [Article Type] Research Article
Biologic interventions for fatigue in rheumatoid arthritisarticle Published on 2016-06-062024-09-04 Journal: The Cochrane database of systematic reviews [Category] 대상포진, [키워드] abatacept Abatacept/therapeutic use adalimumab Adalimumab/therapeutic use Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Antibodies, Monoclonal, Humanized/therapeutic use Antibodies, Monoclonal/therapeutic use antirheumatic agents Antirheumatic Agents/therapeutic use Arthritis, Rheumatoid Arthritis, Rheumatoid/complications Arthritis, Rheumatoid/drug therapy certolizumab pegol Certolizumab Pegol/therapeutic use Etanercept Etanercept/therapeutic use fatigue Fatigue/drug therapy Fatigue/etiology Fatigue/therapy humans Immunosuppressive agents Immunosuppressive Agents/therapeutic use infliximab Infliximab/therapeutic use Interferon‐gamma randomized controlled trials as topic rituximab Rituximab/therapeutic use [DOI] 10.1002/14651858.CD008334.pub2 PMC 바로가기 [Article Type] article
Efficacy of Adalimumab in Korean Patients with Crohn’s DiseaseOriginal Article Published on 2016-03-192024-09-04 Journal: Gut and liver [Category] 대상포진, [키워드] adalimumab Crohn disease remission induction Treatment outcome [DOI] 10.5009/gnl15165 PMC 바로가기 [Article Type] Original Article
Effectiveness and Safety of Immunomodulators with Anti-TNF Therapy in Crohn’s DiseaseArticle Published on 2015-05-122024-09-04 Journal: Clinical gastroenterology and hepatology : the off [Category] 대상포진, [키워드] adalimumab Hospitalization Infection infliximab surgery thiopurines [DOI] 10.1016/j.cgh.2015.02.017 PMC 바로가기 [Article Type] Article
Adverse events in IBD: to stop or continue immune suppressant and biologic treatmentArticle Published on 2014-07-102024-09-04 Journal: Expert review of gastroenterology & hepatology [Category] 대상포진, [키워드] adalimumab azathioprine certolizumab pegol Crohn’s disease Inflammatory bowel disease infliximab mercaptopurine methotrexate Natalizumab ulcerative colitis [DOI] 10.1586/17474124.2014.881715 PMC 바로가기 [Article Type] Article
Risk of herpes zoster in psoriatic patients undergoing biologic treatment피부과 환자가 생물학적 치료를 받을 때 대상포진 발병 위험.Case Reports Published on 2014-02-012023-06-01 Journal: The Journal of dermatology [Category] 대상포진, 두창, 수두, 홍역, [키워드] adalimumab biologic herpes zoster infliximab psoriasis ustekinumab [DOI] 10.1111/1346-8138.12370 [Article Type] Case Reports
A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial)Study Protocol Published on 2014-01-092024-09-02 Journal: Trials [Category] 대상포진, [키워드] adalimumab juvenile idiopathic arthritis methotrexate ophthalmology paediatric rheumatology Safety Uveitis [DOI] 10.1186/1745-6215-15-14 PMC 바로가기 [Article Type] Study Protocol